| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8647527 | Multiple Sclerosis and Related Disorders | 2018 | 12 Pages |
Abstract
The characteristics of pediatric MS patients in Slovenia disclose higher annual relapse rates than in adults but also favorable impact of disease modifying treatment on a clinical course. Our data suggest a good treatment tolerance but also the influence of the formulation on a decision to start or switch the treatment.
Keywords
VEPauditory brainstem evoked potentialsSSEPMTXIVIgEDSSDMTCISMRIEpidemiologyIntravenous immunoglobulinsinterferon-betaMagnetic resonance imagingdisease-modifying treatmentSomatosensory evoked potentialsclinically isolated syndromeCerebrospinal fluidCSFMethotrexateExpanded Disability Status Scalesecondary progressive multiple sclerosisprimary progressive multiple sclerosisrelapsing-remitting multiple sclerosisMultiple sclerosisOutcomeVisual evoked potentialsTreatment responseEvoked potentialsChildrenglatiramer acetate
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
N. Krajnc, J. Oražem, Z. Rener-Primec, M.J. Kržan,